Clinical Trials Browser

Phase 4 × Interventional × Uterine Neoplasms × Clear all

Urogenital Diseases, Uterine Cervical Diseases, Uterine Cervical Neoplasms, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Female, Neoplasms by Site, Uterine Diseases, Uterine Neoplasms, Female Urogenital Diseases

NCT01953107 2021-05-12

Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.

Phase 4 Completed

200 enrolled

Classical hematologyGynecologic

Anemia, Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

NCT03423082 2020-10-28

Pilot Study to Assess the Potential Clinical Utility of 18F Fluciclovine PET for Cervical and Endometrial Cancer.

Phase 4 Terminated

1 enrolled 4 charts

Gynecologic

Uterine Cervical Neoplasms, Uterine Neoplasms

NCT01432015 2017-03-28

Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting

Phase 4 Completed

20 enrolled 5 charts

Gynecologic

Ovarian Neoplasms, Uterine Neoplasms, Vomiting

NCT01492179 2014-05-28

The Effect of Nutritional Counseling for Cancer Patients

Phase 4 Completed

61 enrolled

GastrointestinalGynecologic

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms, Uterine Neoplasms

NCT00628901 2012-07-11

A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)

Phase 4 Completed

60 enrolled 39 charts

Gynecologic

Leiomyoma, Menorrhagia, Uterine Neoplasms, Leiomyomatosis

Clinical Trials

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.

Pilot Study to Assess the Potential Clinical Utility of 18F Fluciclovine PET for Cervical and Endometrial Cancer.

Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting

PoPuLAR

The Effect of Nutritional Counseling for Cancer Patients

A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)